Pramipexole Dihydrochloride Extended-Release
NDC 69680-145, Pramipexole Dihydrochloride, tablet, extended release, from Vitruvias Therapeutics, Inc..
- Product NDC
- 69680-145
- Status
- Listed
- Labeler
- Vitruvias Therapeutics, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212797
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69680-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE.375 mg/1
Pharmacologic classes
Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69680-145-30 | 69680014530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-145-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d07aad1b-e078-4fca-8386-ca2e8e899688NADAC price for package 69680014530
GET /v1/drugs/nadac/69680014530
Use it
Look up 69680-145 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69680-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69680-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.